Primary hyperparathyroidism: an overview
- PMID: 21747852
- PMCID: PMC3124277
- DOI: 10.1155/2011/251410
Primary hyperparathyroidism: an overview
Abstract
Primary hyperparathyroidism is a common condition that affects 0.3% of the general population. Primary and tertiary care specialists can encounter patients with primary hyperparathyroidism, and prompt recognition and treatment can greatly reduce morbidity and mortality from this disease. In this paper we will review the basic physiology of calcium homeostasis and then consider genetic associations as well as common etiologies and presentations of primary hyperparathyroidism. We will consider emerging trends in detection and measurement of parathyroid hormone as well as available imaging modalities for the parathyroid glands. Surgical indications and approach will be reviewed as well as medical management of primary hyperparathyroidism with bisphosphonates and calcimimetics.
References
-
- Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. Journal of Bone and Mineral Research. 2006;21(1):171–177. - PubMed
-
- Mihai R, Wass JA, Sadler GP. Asymptomatic hyperparathyroidism—need for multicentre studies. Clinical Endocrinology. 2008;68(2):155–164. - PubMed
-
- Melton LJ., Jr. The epidemiology of primary hyperparathyroidism in North America. Journal of Bone and Mineral Research. 2002;17(supplement 2):N12–N17. - PubMed
-
- Unger S, Paul DA, Nino MC, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. European Journal of Pediatrics. 2005;164(4):236–243. - PubMed
-
- George J, Acharya SV, Bandgar TR, Menon PS, Shah NS. Primary hyperparathyroidism in children and adolescents. Indian Journal of Pediatrics. 2010;77(2):175–178. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
